- Intellicell Biosciences (OTCPK:SVFC +5.9%) determines that its financial statements for the quarters ended September 30, 2013 and March 31, 2014 and fiscal year ended December 31, 2013 can no longer be relied upon to be GAAP compliant and will need to be restated.
- It is in the process of re-auditing the statements as well as assessing the effectiveness of its internal controls over financial reporting.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs